Skip to main content

Medically reviewed on 5 October 2026 by Dr. Taimoor Asghar.

Your inputs never leave your device. Report an error in this calculator

PESI Score Calculator: Pulmonary Embolism Severity Index

Estimate 30-day mortality in confirmed pulmonary embolism from 11 bedside variables. Prognostic only: this score does not diagnose pulmonary embolism.

Medically reviewed by , physician.

In short: Estimate 30-day mortality in confirmed pulmonary embolism from 11 bedside variables. Prognostic only: this score does not diagnose pulmonary embolism. Use the calculator above, then read the guide below to interpret your result and its limitations.

Calculate the PESI score

Demographics
Comorbidities
Clinical findings at presentation
Bar chart of the 11 PESI variables and their point values, alongside the five PESI risk classes with 30-day mortality ranges
Points assigned to each of the 11 PESI variables (left) and the five PESI risk classes with their 30-day mortality ranges (right). Based on Aujesky et al., 2005.

The PESI score explained

What the PESI score is

The Pulmonary Embolism Severity Index (PESI) is a clinical prediction rule that estimates the risk of death within 30 days in patients with confirmed pulmonary embolism (PE). It combines 11 routinely available clinical variables into a single point total, which is then grouped into one of five risk classes. The score was derived and validated by Aujesky and colleagues in a cohort of 15,531 patients with PE treated at 186 hospitals, and the results were published in 2005.

The most important thing to understand about PESI is what it does not do. It is a prognostic tool, not a diagnostic tool. It cannot tell you whether a patient has a pulmonary embolism; that diagnosis must already be established, usually by CT pulmonary angiography or a ventilation perfusion scan. PESI answers a different question: now that PE is confirmed, how likely is this patient to die in the next 30 days, and is hospital admission necessary, or could the patient be treated safely at home? That question matters because PE ranges from a small clot in a stable patient to a life threatening emergency, and treating every patient as high risk wastes hospital resources while treating a high risk patient as an outpatient can be dangerous.

How the score was developed

The original study used a derivation cohort of 10,354 discharged patients with PE to build the prediction rule. The rule was then tested in two separate populations: an internal validation cohort of 5,177 patients from the same hospitals, and an external validation cohort drawn from a different health system. This three stage design (derivation, internal validation, external validation) is the reason clinicians trust the score more than a rule tested only on the patients used to create it.

Candidate predictors were screened using logistic regression, a statistical method that identifies which variables are independently associated with the outcome after accounting for the others. The final model kept 11 variables: two demographic characteristics (age and male sex), three comorbid illnesses (cancer, heart failure, and chronic lung disease), and six clinical findings measured at presentation (pulse rate, systolic blood pressure, respiratory rate, body temperature, mental status, and arterial oxygen saturation). Points were assigned in proportion to each variable's regression coefficient, which is why the weights differ so much: altered mental status contributes 60 points while heart failure contributes only 10.

The score's discriminatory power, its ability to distinguish patients who died within 30 days from those who survived, was measured as the area under the receiver operating characteristic curve. It was 0.78 in the derivation cohort, 0.77 in the internal validation cohort, and 0.79 in the external validation cohort, showing consistent performance across populations. Overall 30-day mortality was 9.2 percent in the derivation sample and 9.5 percent in the internal validation sample. The external validation sample had a lower overall mortality of 2.7 percent, which the authors attributed to a lower prevalence of comorbid illnesses in that population.

The 11 variables and their points

Every patient starts with points equal to their age in years, so age is the single largest contributor for most patients. The remaining ten variables add fixed points when present:

The 11 variables and their points table
VariableCriterionPoints
AgePoints equal age in yearsAge in years
Male sexMale+10
CancerActive cancer or history of cancer+30
Heart failureHistory of heart failure+10
Chronic lung diseaseHistory of chronic lung disease+10
Pulse rate110 beats per minute or higher+20
Systolic blood pressureBelow 100 mmHg+30
Respiratory rate30 breaths per minute or higher+20
Body temperatureBelow 36 degrees C+20
Altered mental statusDisorientation, lethargy, stupor, or coma+60
Arterial oxygen saturationBelow 90 percent, with or without supplemental oxygen+20

A few details deserve emphasis. The oxygen saturation criterion applies whether or not the patient is receiving supplemental oxygen, so a saturation below 90 percent on oxygen still scores. Altered mental status was defined in the original study as disorientation, lethargy, stupor, or coma, and at 60 points it is by far the heaviest single variable: a patient with altered mental status reaches at least class III on that finding alone if they are over 26 years old, and usually class IV or V. The vital sign cutoffs are strict inequalities or inclusive thresholds exactly as published: pulse 110 or higher, systolic pressure strictly below 100, respiratory rate 30 or higher, temperature strictly below 36, saturation strictly below 90.

Worked example

Consider a 68-year-old man with a history of cancer who presents with a pulse of 118 beats per minute, systolic blood pressure of 95 mmHg, respiratory rate of 32 per minute, temperature of 36.5 degrees C, normal mental status, and oxygen saturation of 93 percent on room air. He has no heart failure and no chronic lung disease. The points add up as follows: 68 for age, 10 for male sex, 30 for cancer, 20 for pulse of 110 or higher, 30 for systolic pressure below 100, and 20 for respiratory rate of 30 or higher, giving a total of 178. Temperature of 36.5 does not score (it is not below 36), saturation of 93 does not score, and the absent findings add nothing. A total of 178 places him in class V, very high risk, with an estimated 30-day mortality of 10.0 to 24.5 percent. Contrast this with a 40-year-old woman with no comorbidities, normal vital signs, and normal oxygenation: her score is simply her age, 40, which is class I, very low risk, with 30-day mortality of 0 to 1.6 percent.

Risk classes and 30-day mortality

The total score maps to five risk classes. The mortality ranges below span the derivation, internal validation, and external validation cohorts of the original study:

Risk classes and 30-day mortality table
Risk classScore rangeRisk level30-day mortality
Class I65 or lessVery low0-1.6%
Class II66 to 85Low1.7-3.5%
Class III86 to 105Intermediate3.2-7.1%
Class IV106 to 125High4.0-11.4%
Class VMore than 125Very high10.0-24.5%

The steep rise across classes is the score's main message: mortality climbs from under 2 percent in class I to as high as roughly 1 in 4 in class V. The ranges, rather than single figures, reflect real variation between the study cohorts, and they remind the user that the score gives a risk stratum, not a precise individual probability.

What the result means for patient care

Classes I and II are considered low risk, and identifying these patients is the score's most important clinical use. Historically, nearly all patients with acute PE were admitted to hospital. The PESI score made it possible to select low risk patients for outpatient management. This approach was tested directly in a randomized non-inferiority trial that allocated 344 patients with low risk PE (PESI classes I and II) to outpatient versus inpatient treatment. Ninety-day mortality was 0.6 percent in both groups, supporting the safety of outpatient care with low molecular weight heparin for carefully selected low risk patients. In practice, the disposition decision still requires clinical judgment: bleeding risk, the patient's social support, the ability to return promptly for care, and comorbidities not captured by the score all matter.

Class III represents intermediate risk; these patients are generally admitted for observation and anticoagulation. Classes IV and V carry high and very high short term mortality and warrant inpatient care with close monitoring. In patients with hemodynamic instability, guidelines recommend considering reperfusion therapy, and the PESI class helps frame how aggressive monitoring should be, even though the decision for thrombolysis or embolectomy rests on hemodynamics and imaging rather than the score alone. Across all classes, PESI supports but never replaces clinical judgment, and it should be used alongside assessment of right ventricular function on imaging and cardiac biomarkers where guidelines call for them.

PESI and the simplified sPESI

Clinicians sometimes confuse the original PESI with the simplified PESI, known as sPESI. This is a separate, shorter tool published in 2010, designed to be easier to remember and calculate at the bedside. It uses six variables, each worth exactly one point: age over 80 years, history of cancer, chronic cardiopulmonary disease, pulse 110 beats per minute or higher, systolic blood pressure below 100 mmHg, and oxygen saturation below 90 percent. A score of 0 identifies low risk patients, while a score of 1 or more identifies higher risk patients. Validation studies found its prognostic performance similar to the original score. This calculator implements only the original 11-variable PESI; sPESI is mentioned here so users do not mix the two instruments or their cutoffs.

Limitations of the PESI score

Like every prediction rule, PESI has boundaries that users should respect. It was derived and validated in adult patients with confirmed PE, so it should not be applied to children, and data in pregnancy are limited. In the external validation cohort, patients with cognitive impairment had been excluded from the underlying study, so altered mental status was assumed to be normal for those patients; the score's performance in patients with genuine neurological impairment is therefore less certain than in the derivation population.

The outcome the score predicts is death from any cause within 30 days, not death specifically caused by the embolism, and it does not predict recurrent venous thromboembolism or bleeding on anticoagulation. The score also ignores information that modern guidelines consider important for intermediate risk patients, including right ventricular dysfunction on echocardiography or CT and elevated cardiac biomarkers such as troponin. A final caveat concerns age: because points equal age in years, an otherwise healthy 90-year-old scores at least 90 (class III) before any other variable is considered. The score remains valid in older patients, but the number should always be interpreted in full clinical context rather than as an automatic admission order.

How to use this calculator

Enter all 11 values above and press "Calculate PESI score". Every field is required; the calculator will flag any missing, invalid, or out of range entry. The result shows the total score, the risk class, the corresponding 30-day mortality range, and a breakdown of how many points each variable contributed, so you can see exactly what is driving the risk. Because this page is educational, always discuss the result with the treating clinician before making any care decision. Pulmonary embolism is a medical emergency: sudden breathlessness, chest pain, or coughing blood requires urgent medical attention, not an online calculator.

Key takeaways

  • No.
  • A PESI score of 65 or less (class I) or 66 to 85 (class II) places the patient in the low risk group, with a 30-day mortality of 0 to 1.6 percent in class I and 1.7 to 3.5 percent in class II.
  • The simplified PESI (sPESI) is a separate, shorter tool published in 2010.
  • In the original Aujesky study, altered mental status was defined as disorientation, lethargy, stupor, or coma.

Frequently asked questions

Is the PESI score a test that diagnoses pulmonary embolism?

No. The PESI score is a prognostic tool, not a diagnostic tool. It is calculated only after pulmonary embolism has been confirmed, usually by CT pulmonary angiography or a ventilation perfusion scan, and it estimates the patient's risk of dying within 30 days. It must not be used to decide whether a patient has a pulmonary embolism.

What does a low PESI score mean?

A PESI score of 65 or less (class I) or 66 to 85 (class II) places the patient in the low risk group, with a 30-day mortality of 0 to 1.6 percent in class I and 1.7 to 3.5 percent in class II. In a randomized trial of 344 low risk patients, outpatient treatment was non-inferior to hospital admission, with 90-day mortality of 0.6 percent in both groups, so carefully selected class I and II patients may be treated at home. The decision always requires clinical judgment and assessment of bleeding risk, social support, and the ability to return for care.

What is the difference between PESI and sPESI?

The simplified PESI (sPESI) is a separate, shorter tool published in 2010. It uses six variables, each worth one point: age over 80 years, history of cancer, chronic cardiopulmonary disease, pulse 110 beats per minute or higher, systolic blood pressure below 100 mmHg, and oxygen saturation below 90 percent. A score of 0 identifies low risk patients, while a score of 1 or more identifies higher risk patients. The original 11-variable PESI remains the more granular score.

What counts as altered mental status in the PESI score?

In the original Aujesky study, altered mental status was defined as disorientation, lethargy, stupor, or coma. It carries the largest single weight in the score at 60 points, so a patient with altered mental status almost always falls into a high risk class.

How accurate is the PESI score?

In the original study, the score's ability to discriminate between patients who died and survived within 30 days, measured as the area under the receiver operating characteristic curve, was 0.78 in the derivation cohort, 0.77 in the internal validation cohort, and 0.79 in the external validation cohort. These values indicate consistent, moderately good performance across different patient populations.

Can the PESI score be used in children or during pregnancy?

No. The score was derived and validated in adult patients with confirmed pulmonary embolism, and it has not been validated in children. Data in pregnancy are limited. In these groups, risk assessment should rely on specialist clinical judgment rather than the PESI score.

References

  1. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041-1046.
  2. Review of the Pulmonary Embolism Severity Index (PESI) calculator. Evidence to Action: Official Journal of MDCalc. Tabulates 30-day mortality by risk class across the derivation, internal validation, and external validation cohorts. Available from: https://mdcalc.scholasticahq.com/article/164333.pdf
  3. Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383-1389.
  4. Aujesky DR, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41-48.
  5. American Society of Hematology
  6. National Cancer Institute

Medical disclaimer: This calculator is for educational and informational purposes only. It does not provide medical advice, diagnosis, or treatment, and it does not replace the judgment of a qualified clinician. Pulmonary embolism is a medical emergency: sudden breathlessness, chest pain, or coughing blood requires urgent medical attention. Always discuss the result with the treating clinician before making any care decision.